ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 205 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $359,000 | -95.9% | 5,978 | -95.8% | 0.03% | -96.2% |
| Q4 2014 | $8,695,000 | -1.8% | 140,839 | -38.3% | 0.76% | -11.1% |
| Q3 2014 | $8,858,000 | +41.4% | 228,119 | +25.5% | 0.85% | +47.4% |
| Q2 2014 | $6,264,000 | -6.9% | 181,839 | +16.8% | 0.58% | -10.4% |
| Q1 2014 | $6,729,000 | -60.1% | 155,738 | -58.8% | 0.64% | -36.1% |
| Q4 2013 | $16,850,000 | +51.6% | 378,086 | +27.7% | 1.01% | +31.0% |
| Q3 2013 | $11,118,000 | +198.5% | 296,156 | +113.6% | 0.77% | +21.7% |
| Q2 2013 | $3,725,000 | – | 138,638 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
| HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
| DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
| GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
| WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
| SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
| AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
| PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
| NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |